NCT07117747

Brief Summary

When absorbent hygiene products-such as panty liners, sanitary pads, incontinence products, or wound care items-are used over extended periods, they can sometimes have negative effects on the skin. The aim of the current study is to investigate the best way to measure the amount of cytokines on the skin through a non-invasive method. Cytokines are small proteins that act as signaling molecules in the immune system and regulate inflammation and the body's response to infections. Because inflammatory markers often appear in very low concentrations in skin surface samples, it is essential to optimize both collection and extraction methods to overcome this limitation. The researchers want to evaluate different sampling and extraction techniques to measure the skin's inflammatory response. The effectiveness assessment involves determining how well these methods can detect and analyze inflammatory markers. This includes ensuring the sampling methods are non-invasive yet sensitive enough to detect subtle changes in skin inflammation. Furthermore, the extraction methods must efficiently isolate relevant biomarkers to provide reliable data on the skin's response to the products.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 5, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 12, 2025

Completed
Last Updated

August 12, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

August 5, 2025

Last Update Submit

August 5, 2025

Conditions

Keywords

Absorbing hygiene productSkin samplingCytokines

Outcome Measures

Primary Outcomes (1)

  • Cytokine detection

    the detection of cytokines obtained by the different extraction solvents and sampling methods. ELISA complemented with the Micro BCA Protein Assay were used to quantify the cytokine recovery (in pg/ug total soluble protein).

    1-2 months

Study Arms (1)

Healthy volunteers

EXPERIMENTAL

Single arm study

Other: Healthy volunteers

Interventions

All subject belong to the same arm and ther is no intervention

Healthy volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sex: men/women
  • Age: \>18 years
  • Subjects with full legal competence
  • Subjects who have provided a signed informed consent and willing to come to the scheduled visit at the test site

You may not qualify if:

  • Subjects that have participated in any skin test that could cause damage to the skin barrier during the last 2 weeks
  • Subjects that have participated in any skin test that could cause damage to the skin barrier during the last 2 weeks
  • Subjects with known sensitivity or allergy to adhesives and nylon
  • Have immunodeficiency, taking any anti-inflammatory medication or having any other condition that makes participation in the clinical investigation inappropriate, as judged by investigator
  • Subjects with hairy forearms
  • Subjects with active skin diseases on the forearms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Essity Study Site

Mölndal, Sweden

Location

Study Officials

  • Warangkana Lohcharoenkal, PhD

    Essity Hygiene and Health AB

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Samples are taken from the forearms of healthy individuals at two visits and the amount of cytokines that can be retrieved from the samples re extracted using various methods in order to optimize the protocol.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2025

First Posted

August 12, 2025

Study Start

March 1, 2025

Primary Completion

April 29, 2025

Study Completion

July 22, 2025

Last Updated

August 12, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations